bioAffinity Technologies (BIAF) Treasury Shares (2021)

bioAffinity Technologies (BIAF) has reported Treasury Shares for 6 consecutive years, with $51810.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Treasury Shares fell 96.7% year-over-year to $51810.0; the TTM figure through Mar 2026 stood at $51810.0 (down 96.7% YoY), while the FY2025 annual figure was $51810.0, up 17.06% from the prior year.
• Treasury Shares steadied at $51810.0 in Q1 2026 per BIAF's latest filing, from $51810.0 in the prior quarter.
• Across five years, Treasury Shares topped out at $1.6 million in Q1 2025 and bottomed at $44261.0 in Q4 2024.
• Historically, Treasury Shares has averaged $641512.2 across 5 years, with a median of $540969.0 in 2023.
• Annual changes were most pronounced in 2023 — Treasury Shares surged 370.74% — and 2026, when it plunged 96.7%.
• bioAffinity Technologies' Treasury Shares stood at $114920.0 in 2022, then surged by 370.74% to $540969.0 in 2023, then sank by 91.82% to $44261.0 in 2024, then advanced by 17.06% to $51810.0 in 2025, then changed by 0.0% to $51810.0 in 2026.
• Business Quant data shows BIAF's Treasury Shares at $51810.0 in Q1 2026, $51810.0 in Q4 2025, and $51849.0 in Q3 2025.